At a glance
ClinicalIndex Comparison RecordN/ACompleted· 522 target
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Prospective Study of the Determinants of Host Resistance to HIV-1 Infection
National Institute of Allergy and Infectious Diseases (NIAID)·observational·Posted Jul 12, 2006·Updated Apr 9, 2014
In Brief
An observational study for HIV Infections. Completed, enrolled 522 participants across 3 sites in 2 countries.
Detailed Summary
Some people who are exposed to the HIV-1 virus are capable of either controlling or completely preventing viral infection. Multiple genetic factors may contribute to preventing or controlling HIV-1 infection. The purpose of this study is to analyze the immune system responses of individuals who are exposed to HIV-1 but remain uninfected.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHIV Infections
CountriesUganda, United Kingdom
CollaboratorsCenter for HIV/AIDS Vaccine Immunology
Timeline
N/ACompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJul 2006
Enrollment StartFeb 2007
Primary CompletionSep 2010
TodayJul 2026
First PostedJul 12, 2006
Enrollment StartFeb 1, 2007
Primary CompletionSep 1, 2010
TodayJul 2, 2026
Enrollment to primary: 3.6 yearsPosted 20.0 years ago